Trial Profile
An open, randomized, three-way crossover study assessing the effect of food intake on the pharmacokinetics (PK) and tolerability of single oral administration of YH4808 in healthy Korean volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs YH 4808 (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Pharmacokinetics
- 22 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics